- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 413/10 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
Patent holdings for IPC class C07D 413/10
Total number of patents in this class: 2118
10-year publication summary
|
161
|
138
|
130
|
151
|
161
|
163
|
139
|
117
|
130
|
36
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Patent GmbH | 5909 |
67 |
| Bristol-myers Squibb Company | 5080 |
61 |
| Takeda Pharmaceutical Company Limited | 2961 |
53 |
| Boehringer Ingelheim International GmbH | 4629 |
47 |
| Merck Sharp & Dohme LLC | 3689 |
42 |
| Novartis AG | 11238 |
39 |
| F. Hoffmann-La Roche AG | 7958 |
30 |
| LG Chem, Ltd. | 17205 |
29 |
| Syngenta Participations AG | 4970 |
29 |
| Bayer Pharma AG | 1096 |
27 |
| AstraZeneca AB | 3042 |
24 |
| Bayer AG | 3045 |
22 |
| BASF SE | 19740 |
21 |
| Janssen Pharmaceutica N.V. | 3839 |
21 |
| Chong Kun Dang Pharmaceutical Corp. | 229 |
21 |
| Taisho Pharmaceutical Co., Ltd. | 844 |
21 |
| Shenyang Sinochem Agrochemicals R&D Co., Ltd. | 98 |
20 |
| Amgen Inc. | 3779 |
18 |
| Glaxosmithkline LLC | 566 |
17 |
| Vertex Pharmaceuticals Incorporated | 1581 |
17 |
| Other owners | 1492 |